Mycotoxin bioaccessibility in baby food through in vitro digestion: an overview focusing on risk assessment

Regarding mycotoxin exposure, weaned infants and young children are a particular vulnerable subgroup when compared to adults, due to their distinct metabolic rates and lower body weight. In this review, the occurrence and co-occurrence of mycotoxins in baby food and values of daily intakes are presented. Since not all mycotoxin content described by occurrence studies are available during the digestion process there is a critical relevance in studies of bioaccessibility. In this context, a summary of the main baby food bioaccessibility assays and their findings are shown and discussed. In addition, general aspects of the most recent advances in strategies to reduce the bioaccessibility of mycotoxin are also presented.

Automated summary

Weaned infants and young children are more vulnerable to mycotoxin exposure compared to adults. The review focuses on the occurrence and co-occurrence of mycotoxins in baby food, as well as the importance of studying bioaccessibility. Recent advances in strategies to reduce mycotoxin bioaccessibility are also discussed.